CENTOGENE

Anrufen Wegbeschreibung Website Service kontaktieren

CENTOGENE Guiding Precision Medicine. CENTOGENE - transforming genetic data into medical decisions.

We are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives us a unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. We focus exclusively on providing the highest quality, patient-centred service, verified by multiple international accreditations (ISO, CAP, CLIA), regular pharmaceutical audits and our outstanding short turn-around times for analysis. We believe our medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Our mutation database (CentoMD®) is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. CENTOGENE is a key partner for many high-profile pharmaceutical companies who are active in the orphan drug development.

How is genetic testing shaping the future of oncology? 🧬 Join our next CENTOGENE Webinar: Advancing Precision Oncology –...
16/10/2026

How is genetic testing shaping the future of oncology? 🧬
 
Join our next CENTOGENE Webinar: Advancing Precision Oncology – The Role of Genetic Testing.
 
Our experts will discuss how genetic insights are supporting more personalized approaches in oncology, along with the opportunities and challenges ahead.
 
🎙️ Speakers: Raphael Parmeggiani, PhD & Florentia Fostira, PhD
🎤 Moderator: Eleni Perraki, PhD
 
📅 Thursday, 29 October
🕑 14:00 CET | 13:00 UTC | 09:00 New York | 16:00 Riyadh | 18:30 New Delhi
 
🔗 Registration link in bio. Save the date and share it with a colleague who should be there!
 

Some families start their journey with more questions than others. For couples with a family history of genetic disorder...
01/10/2026

Some families start their journey with more questions than others.
 
For couples with a family history of genetic disorders, an affected partner or consanguinity, carrier screening needs to go further. That is why today we introduce CentoScreen Exome Comprehensive.
 
Our new full gene analysis test covers more than 1,900 genes associated with autosomal recessive or X-linked disorders, with interpretation that takes into account previous results, family history and other important clinical information for the couple.
 
And it goes beyond carrier screening, with an optional WES diagnostic analysis: an exome approach that opens the possibility of phenotype-based analysis.
 
In reproductive genetics, every finding changes the way we manage the next stage. For high risk couples, this is where the journey begins.
 
PrecisionMedicine Genomics

❤️ Today is hashtag Some heart conditions run in families — and often go unnoticed for years.Understanding our genes can...
29/09/2026

❤️ Today is hashtag

Some heart conditions run in families — and often go unnoticed for years.

Understanding our genes can help families get answers sooner and take care of their hearts together.

At CENTOGENE, we are proud to support patients, families and doctors around the world on that journey. 💙

We are excited to share that CENTOGENE will present three scientific posters at ASHG 2026, exploring how genome sequenci...
24/09/2026

We are excited to share that CENTOGENE will present three scientific posters at ASHG 2026, exploring how genome sequencing can address that challenge across different clinical settings: hereditary ataxias caused by repeat expansions, reproductive carrier screening for complex gene variants, and rare disease diagnostics in challenging variant contexts.
 
📍 Palais des Congrès de Montréal
👋 Visit us at Booth #1301 during the congress to discuss the work with our experts.
 
We look forward to exchanging ideas with researchers, clinicians and industry colleagues on how genomic diagnostics can bring more patients closer to an answer. Swipe through to see the full program.

Precision medicine only matters if people can understand it.Our website is now available in 5 languages, so patients, fa...
21/09/2026

Precision medicine only matters if people can understand it.

Our website is now available in 5 languages, so patients, families, and healthcare professionals can explore CENTOGENE in the language they know best.

Choose your language at centogene.com (link in bio).

04/08/2026

No summer schedule. No summer closures.
Same hours, same days — your samples, our priority, all August.

Non-Invasive Prenatal Testing Portfolio Update – Now with CentoNIPT Expanded Expertise You Can TrustOur CentoNIPT portfo...
22/07/2026

Non-Invasive Prenatal Testing Portfolio Update – Now with CentoNIPT Expanded
 
Expertise You Can Trust
Our CentoNIPT portfolio continues to grow with the addition of CentoNIPT Expanded, offering broader prenatal screening to support informed clinical decision-making.
 
NEW: CentoNIPT Expanded now offers:
✅ Available for singleton and twin pregnancies
✅ Comprehensive screening for fetal chromosome aneuploidies across all chromosomes
✅ Detection of partial deletions and duplications of ≥ 7 Mb across all autosomes
✅ Optional fetal s*x reporting
✅ Optional reporting of s*x chromosome aneuploidies (SCAs)
 
By delivering expanded genomic insights from a simple maternal blood sample, CentoNIPT Expanded provides broader prenatal screening to help support informed clinical decision-making throughout pregnancy.
 
CentoNIPT is a fast and accurate non-invasive prenatal screening test that:
• Is performed on a single maternal blood sample
• Can be performed from 10 weeks of gestation
• Combines advanced next-generation sequencing (NGS) technology with high-quality medical reporting
• Screens for the most common fetal chromosomal abnormalities, including Trisomies 21, 18, and 13, as well as s*x chromosome aneuploidies (Monosomy X, XXY, ###, and XYY)
 

Exciting news!CENTOGENE has taken ownership of Pearl Medical Analysis Laboratory in Abu Dhabi, strengthening our commitm...
14/07/2026

Exciting news!

CENTOGENE has taken ownership of Pearl Medical Analysis Laboratory in Abu Dhabi, strengthening our commitment to expanding access to advanced reproductive and genetic testing across the Middle East.

Together, we’re making precision medicine and personalized genetic care more accessible for healthcare professionals, patients, and families.

07/07/2026

We’re excited to launch CentoBiome!

Visit our booth to discover our latest innovation, meet our team, and learn how CentoBiome can make a difference.

We look forward to seeing you at Booth

07/07/2026

Are you at ESHRE 2026?

Come and visit us at Booth and ask for more information about the third generation of PGT-A.

See you here!

Adresse

Am Strande 7
Rostock
18055

Telefon

+4938180113416

Website

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn CENTOGENE etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an CENTOGENE senden:

Verknüpfungen

Teilen